vs
Side-by-side financial comparison of Element Solutions Inc (ESI) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $840.0M, roughly 1.3× Element Solutions Inc). Element Solutions Inc runs the higher net margin — 6.7% vs -127.8%, a 134.5% gap on every dollar of revenue. On growth, Element Solutions Inc posted the faster year-over-year revenue change (41.0% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-74.2M). Over the past eight quarters, Element Solutions Inc's revenue compounded faster (17.1% CAGR vs 1.3%).
Element Solutions Inc is an American specialty chemicals production corporation listed on the New York Stock Exchange.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
ESI vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $840.0M | $1.1B |
| Net Profit | $56.0M | $-1.4B |
| Gross Margin | 38.4% | 32.6% |
| Operating Margin | 13.3% | -116.0% |
| Net Margin | 6.7% | -127.8% |
| Revenue YoY | 41.0% | -2.5% |
| Net Profit YoY | -42.9% | -3093.9% |
| EPS (diluted) | $0.23 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $840.0M | — | ||
| Q4 25 | $676.2M | $1.1B | ||
| Q3 25 | $656.1M | $1.0B | ||
| Q2 25 | $625.2M | $1.1B | ||
| Q1 25 | $593.7M | $1.0B | ||
| Q4 24 | $624.2M | $1.1B | ||
| Q3 24 | $645.0M | $1.1B | ||
| Q2 24 | $612.7M | $1.1B |
| Q1 26 | $56.0M | — | ||
| Q4 25 | $6.2M | $-1.4B | ||
| Q3 25 | $39.3M | $7.5M | ||
| Q2 25 | $47.4M | $-8.4M | ||
| Q1 25 | $98.0M | $-6.4M | ||
| Q4 24 | $54.7M | $-44.4M | ||
| Q3 24 | $40.3M | $-21.0M | ||
| Q2 24 | $93.2M | $-108.4M |
| Q1 26 | 38.4% | — | ||
| Q4 25 | 40.9% | 32.6% | ||
| Q3 25 | 42.2% | 36.1% | ||
| Q2 25 | 42.6% | 34.4% | ||
| Q1 25 | 42.2% | 37.6% | ||
| Q4 24 | 41.0% | 33.9% | ||
| Q3 24 | 41.5% | 37.2% | ||
| Q2 24 | 43.6% | 37.0% |
| Q1 26 | 13.3% | — | ||
| Q4 25 | 10.3% | -116.0% | ||
| Q3 25 | 15.4% | 7.0% | ||
| Q2 25 | 15.1% | 4.3% | ||
| Q1 25 | 13.0% | 4.5% | ||
| Q4 24 | 12.0% | 10.0% | ||
| Q3 24 | 14.7% | 7.4% | ||
| Q2 24 | 15.7% | -2.5% |
| Q1 26 | 6.7% | — | ||
| Q4 25 | 0.9% | -127.8% | ||
| Q3 25 | 6.0% | 0.7% | ||
| Q2 25 | 7.6% | -0.8% | ||
| Q1 25 | 16.5% | -0.6% | ||
| Q4 24 | 8.8% | -3.9% | ||
| Q3 24 | 6.2% | -1.9% | ||
| Q2 24 | 15.2% | -10.2% |
| Q1 26 | $0.23 | — | ||
| Q4 25 | $0.03 | $-10.23 | ||
| Q3 25 | $0.16 | $0.05 | ||
| Q2 25 | $0.20 | $-0.06 | ||
| Q1 25 | $0.40 | $-0.05 | ||
| Q4 24 | $0.22 | $-0.32 | ||
| Q3 24 | $0.17 | $-0.15 | ||
| Q2 24 | $0.39 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.9B |
| Total Assets | $5.7B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.3M | — | ||
| Q4 25 | $626.5M | — | ||
| Q3 25 | $594.3M | $432.1M | ||
| Q2 25 | $529.9M | $454.2M | ||
| Q1 25 | $499.2M | $409.9M | ||
| Q4 24 | $359.4M | $558.8M | ||
| Q3 24 | $376.0M | $1.5B | ||
| Q2 24 | $309.3M | $542.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.9B | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.7B | $4.4B | ||
| Q2 25 | $2.6B | $4.5B | ||
| Q1 25 | $2.5B | $4.4B | ||
| Q4 24 | $2.4B | $4.3B | ||
| Q3 24 | $2.4B | $4.6B | ||
| Q2 24 | $2.4B | $4.5B |
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.1B | $8.5B | ||
| Q3 25 | $5.0B | $10.1B | ||
| Q2 25 | $5.0B | $10.1B | ||
| Q1 25 | $4.8B | $9.8B | ||
| Q4 24 | $4.9B | $9.6B | ||
| Q3 24 | $5.1B | $11.2B | ||
| Q2 24 | $5.0B | $10.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.61× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | 0.64× | — | ||
| Q4 24 | 0.76× | — | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | $-74.2M | $148.6M |
| FCF MarginFCF / Revenue | -8.8% | 13.4% |
| Capex IntensityCapex / Revenue | 3.0% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $175.4M | ||
| Q3 25 | $100.1M | $51.7M | ||
| Q2 25 | — | $75.9M | ||
| Q1 25 | $26.0M | $-64.5M | ||
| Q4 24 | — | $312.6M | ||
| Q3 24 | $98.5M | $42.2M | ||
| Q2 24 | — | $9.5M |
| Q1 26 | $-74.2M | — | ||
| Q4 25 | — | $148.6M | ||
| Q3 25 | $83.6M | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | $15.0M | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | $85.9M | $15.1M | ||
| Q2 24 | — | $-18.9M |
| Q1 26 | -8.8% | — | ||
| Q4 25 | — | 13.4% | ||
| Q3 25 | 12.7% | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | 2.5% | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | 13.3% | 1.4% | ||
| Q2 24 | — | -1.8% |
| Q1 26 | 3.0% | — | ||
| Q4 25 | 2.5% | 2.4% | ||
| Q3 25 | 2.5% | 2.1% | ||
| Q2 25 | 2.8% | 1.8% | ||
| Q1 25 | 1.9% | 2.4% | ||
| Q4 24 | 3.6% | 3.3% | ||
| Q3 24 | 2.0% | 2.5% | ||
| Q2 24 | 2.4% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.55× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.44× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESI
| Electronics ex-Metals | $377.8M | 45% |
| Pass-through Metals | $255.7M | 30% |
| Other | $206.5M | 25% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
